AIP
OLMA icon

Ameritas Investment Partners’s Olema Pharmaceuticals OLMA Stock Holding History

Ameritas Investment Partners’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.2K Buy
5,716
+741
+15% +$16.5K ﹤0.01% 1779
2025
Q4 		$124K Hold
4,975
– – ﹤0.01% 1566
2025
Q3 		$48.7K Sell
4,975
-1,105
-18% -$6.63K ﹤0.01% 2141
2025
Q2 		$25.9K Buy
6,080
+2,168
+55% +$9.67K ﹤0.01% 2545
2025
Q1 		$14.7K Hold
3,912
– – ﹤0.01% 2675
2024
Q4 		$22.8K Hold
3,912
– – ﹤0.01% 2572
2024
Q3 		$46.7K Hold
3,912
– – ﹤0.01% 2231
2024
Q2 		$42.3K Buy
3,912
+1,695
+76% +$18.4K ﹤0.01% 2234
2024
Q1 		$25.1K Hold
2,217
– – ﹤0.01% 2471
2023
Q4 		$31.1K Hold
2,217
– – ﹤0.01% 2389
2023
Q3 		$27.4K Hold
2,217
– – ﹤0.01% 2404
2023
Q2 		$20K Buy
+2,217
New +$13.4K ﹤0.01% 2565
2022
Q2 		– Sell
-1,931
Closed -$8K – 3185
2022
Q1 		$8K Hold
1,931
– – ﹤0.01% 2862
2021
Q4 		$18K Hold
1,931
– – ﹤0.01% 2689
2021
Q3 		$53K Buy
1,931
+944
+96% +$25.5K ﹤0.01% 2114
2021
Q2 		$28K Hold
987
– – ﹤0.01% 2551
2021
Q1 		$33K Buy
+987
New +$42.3K ﹤0.01% 2318

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Ameritas Investment Partners's OLMA Position: Q1 2026 in Review

Ameritas Investment Partners increased its Olema Pharmaceuticals (OLMA) stake by 15% in Q1 2026, buying an estimated $16.5K and bringing the position to 5,716 shares worth $85.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

Ameritas Investment Partners first reported a position in OLMA in Q1 2021 and has held it in 17 quarters since. The position peaked at $124K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Ameritas Investment Partners held 5,716 shares of Olema Pharmaceuticals worth $85.2K as of Q1 2026.
  • Ameritas Investment Partners bought 741 Olema Pharmaceuticals shares in Q1 2026, an estimated $16.5K.
  • Olema Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1779 holding.
  • Ameritas Investment Partners first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 17 quarters since.
  • Ameritas Investment Partners's Olema Pharmaceuticals position peaked at $124K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.